WO2019219758A1 - Processes in the preparation of polyunsaturated ketone compounds - Google Patents

Processes in the preparation of polyunsaturated ketone compounds Download PDF

Info

Publication number
WO2019219758A1
WO2019219758A1 PCT/EP2019/062506 EP2019062506W WO2019219758A1 WO 2019219758 A1 WO2019219758 A1 WO 2019219758A1 EP 2019062506 W EP2019062506 W EP 2019062506W WO 2019219758 A1 WO2019219758 A1 WO 2019219758A1
Authority
WO
WIPO (PCT)
Prior art keywords
polyunsaturated
formula
steps
solvent
water
Prior art date
Application number
PCT/EP2019/062506
Other languages
French (fr)
Inventor
Marcel Sandberg
Inger Reidun Aukrust
Original Assignee
Avexxin As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avexxin As filed Critical Avexxin As
Publication of WO2019219758A1 publication Critical patent/WO2019219758A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/14Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of a —CHO group
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00Thiocarboxylic acids
    • C07C327/20Esters of monothiocarboxylic acids
    • C07C327/22Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/56Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds
    • C07C45/57Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom
    • C07C45/58Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds from heterocyclic compounds with oxygen as the only heteroatom in three-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/09Preparation of carboxylic acids or their salts, halides or anhydrides from carboxylic acid esters or lactones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D301/00Preparation of oxiranes
    • C07D301/02Synthesis of the oxirane ring
    • C07D301/03Synthesis of the oxirane ring by oxidation of unsaturated compounds, or of mixtures of unsaturated and saturated compounds

Definitions

  • This invention relates to a method of making a polyunsaturated epoxide compound and optional subsequent conversion of that epoxide compound into a polyunsaturated ketone.
  • the invention relates to the conversion of a polyunsaturated ester to a polyunsaturated epoxide compound in a single vessel or “pot”.
  • the polyunsaturated epoxide is an intermediate that can then be converted to a polyunsaturated ketone thus enabling the formation of that ketone in fewer steps.
  • the invention significantly reduces or in preferred cases avoids separate work up procedures and thus simplifies the process without a significant reduction in overall yield or purity.
  • the invention relates to the conversion of a polyunsaturated alcohol to a polyunsaturated thioester and optional subsequent conversion of that thioester into a polyunsaturated ketone.
  • the invention relates to the conversion of a polyunsaturated alcohol to a polyunsaturated thioester compound in a single vessel or pot. That polyunsaturated thioester can then be converted to a polyunsaturated ketone thus enabling the formation of that ketone in fewer steps.
  • the invention significantly reduces or in preferred cases avoids separate work up procedures and thus simplifies the process without a significant reduction in overall yield or purity. Background
  • the present inventors sought a process for the manufacture of a polyunsaturated ketone compound that requires fewer steps without a significant reduction in overall yield or purity.
  • the present invention relates to the manufacture of certain intermediates useful in the manufacture of the target compounds as well as an overall process for the preparation of the compounds of the invention.
  • the present inventors have found that a polyunsaturated ester can be converted to a polyunsaturated epoxide in a single reaction vessel or pot.
  • the chemistry described herein avoids or at least reduces the formation of side products and enables the formation of a polyunsaturated epoxide and eventually a
  • polyunsaturated thiol which can be used in further synthetic steps to form desired target polyunsaturated ketone molecules.
  • polyunsaturated epoxide compounds in a single pot.
  • Such polyunsaturated epoxide compounds can ultimately be converted to the advantageous compounds such as the polyunsaturated ketone compounds discussed herein.
  • the method of the invention involves a single step process comprising hydrolysis and then halolactonisation of a polyunsaturated ester and conversion to the corresponding polyunsaturated epoxide. That epoxide can be reduced to a polyunsaturated aldehyde and then polyunsaturated alcohol. The alcohol can be converted to a thioester (of formula -SCOR 4 wherein R 4 is a Ci- 20 hydrocarbyl group) in one pot, with subsequent conversion of the thioester to desired target compounds.
  • the invention provides a process comprising the steps of:
  • the invention provides a process comprising the following steps:
  • step a-ii) treating the product from step a-i), especially the crude product, with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone;
  • steps a-i) to a-iii) are carried out in the same reaction vessel.
  • the invention provides a process comprising the following steps:
  • step a-ii) treating in the vessel the product from step a-i), especially the crude product, with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone;
  • step a-iii) treating in the vessel the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol and water to convert the polyunsaturated halolactone to the corresponding polyunsaturated epoxide lower alkyl ester.
  • the invention provides a process comprising the following steps:
  • R 1 is an optionally substituted CY22 unsaturated hydrocarbon group, said hydrocarbon group comprising at least 2, preferably at least 4 double bonds; and R 6 is a C1-C4 alkyl group;
  • R I -CH CH-CH 2 CH 2 COOH (IF) such as the compound
  • step a-ii) treating the product from step a-i), especially the crude product, with a iodolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone compound
  • step a-iii) treating the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol/water to convert the iodolactone to the corresponding polyunsaturated epoxide lower alkyl ester of formula (IV):
  • the invention provides a process comprising the following steps:
  • R 6 is a C1-C4 alkyl group
  • step a-ii) treating the product from step a-i), especially the crude product, with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding halolactone;
  • step a-iii) treating the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol and water to convert the halolactone to the corresponding epoxide of formula (IX):
  • R 5 is Ci- 4 alkyL
  • steps (a-i) to (a-iii) are carried out in the same reaction vessel.
  • the invention provides a process for the preparation of a polyunsaturated thioester comprising:
  • steps (e) and (f) are carried out consecutively in one vessel.
  • the invention provides a process including at least the following steps:
  • step (f) reacting the reaction product of step (e) with a thioacetate ion to form a thioester of formula:
  • steps (e) and (f) are carried out consecutively in one vessel.
  • step g) the product of step (f) is reacted with a metal carbonate in the presence of an antioxidant to form a thiol of formula:
  • the thiol produced in step (g) is reacted with 3- bromo-l,l,l-trifluoroacetone under conditions that produce compounds A or B:
  • polyunsaturated ester and so on refers to compounds which contains a hydrocarbon chain containing multiple double bonds, i.e. 2 or more. That chain is preferably free of any rings. It is preferred if double bonds present are not conjugated.
  • the chain is preferably aliphatic. In any polyunsaturated ester group, it is preferred if there is a double bond gamma to the carbonyl in order to enable the formation of the halolactone.
  • Any polyunsaturated ester is preferably a lower alkyl ester.
  • the term acid typically refers to a carboxylic acid unless context permits.
  • Hal means halide, i.e. F, Cl, Br or I.
  • Ci-20 hydrocarbyl group refers to a group containing 1 to 20 carbon atoms and H atoms only.
  • the group may be a Ci-io hydrocarbyl group, such as a Ci-10 alkyl group, C2-10 alkenyl, C 6-i o aryl group, C 7 _io alkylaryl, C 7 _ioarylalkyl group, C3-io-cycloalkyl group, C 4-i oalkylcycloalkyl or C 4-i ocycloalkylalkyl group and so on.
  • Any hydrocarbyl group is preferably a Ci_ l oalkyl group.
  • Any hydrocarbyl group is preferably a linear Ci-ioalkyl group.
  • any polyunsaturated compound of the invention will have an Mw of less than 500 g/mol, preferably 450 g/mol or less, more preferably 400 g/mol or less.
  • pharmaceutically acceptable means that which is useful in preparing a pharmaceutical that is generally non-toxic and is not biologically undesirable and includes that which is acceptable for veterinary use and/or human pharmaceutical use.
  • lower alcohol means a Cl -4 alcohol such as methanol or ethanol.
  • lower alkyl means a Cl -4 alkyl.
  • This invention generally relates to processes useful in the preparation of certain polyunsaturated ketone compounds, e.g. of formula R 1 CH 2 -SCH 2 COCF 3 , in particular compounds A and B below.
  • this invention particularly relates to a process for the manufacture of a polyunsaturated epoxide that is a useful intermediate in the synthesis of these compounds.
  • the process offers high yields and high purity but uses fewer separate steps than are used in prior art processes. Remarkably, despite fewer steps, there is no significant loss of purity or yield.
  • the process can also be readily scaled up for industrial operation.
  • the invention provides a way of making a polyunsaturated epoxide intermediate.
  • the invention relates to the subsequent conversion of that polyunsaturated epoxide to a polyunsaturated thioester, then to a polyunsaturated thiol and then to a polyunsaturated ketone.
  • the invention in a second embodiment, relates to the preparation of a polyunsaturated thioester intermediate useful in the formation of compounds like compounds A and B above.
  • the polyunsaturated thioester is obtained from a polyunsaturated alcohol in high yield and purity and preferably without any inter step purification.
  • the combination of embodiments one and two forms a still yet further aspect of the invention.
  • WO2015/011206 (PCT/EP2014/065853) and WO2016/116634 (PCT/EP2016/051456) describe a process in which a polyunsaturated ester is converted, via an epoxide to a polyunsaturated ketone (Scheme 1).
  • the hydrolysis step is performed using LiOH in EtOH/H 2 0, while iodolactonization is performed in THF/water and the epoxide formation takes place in MeOH (leading therefore to the formation of a methyl ester).
  • a work-up step after each one of steps a-i), a-ii) and a-iii).
  • WO2016/116634 also describes step a-i) being carried out in EtOH/H 2 0.
  • a solvent change is needed in step a-ii) where THF/H 2 0 is used.
  • Step a-iii) is then carried out in MeOH.
  • the inventors have now surprisingly established that it is possible to carry out the hydrolysis, halolactonization and epoxidation steps without a change of solvent between each step.
  • the inventors have surprisingly established that it is possible to carry out steps a-i) to a-iii) using a mixture of lower alcohol/H 2 0 in each of the steps. This is surprising because until now it was thought that different solvents were needed for each of steps a-i) to a-iii). Furthermore, it is possible to carry out this sequence of reactions without detriment to epoxide purity or yield.
  • steps a-i) to a-iii) are carried out without any organic and/or aqueous washing steps between steps a-i) and a-ii) and a-ii) to a-iii).
  • steps a-i) to a-iii) are carried out in one pot using the same solvent and ideally without any work up procedures between the steps.
  • the starting material in the process of the invention is a polyunsaturated ester.
  • polyunsaturated alcohol is of formula (G):
  • RI-CH CH-CH 2 CH 2 COOR 6 ( ) wherein Ri is an optionally substituted CY22 unsaturated hydrocarbon group, said hydrocarbon group comprising at least 2, preferably at least 4 double bonds; and R 6 is a C1-C4 alkyl group.
  • the double bond in formula (G) is preferably in cis thus making the compound formula (I):
  • the group Ri preferably comprises 5 to 9 double bonds, preferably 5 or 8 double bonds, e.g. 5 to 7 double bonds such as 5 or 6 double bonds.
  • the group Ri may have between 8 and 22 carbon atoms, preferably 10 to 19 carbon atoms, especially 16 to 18 carbon atoms. Carbon atoms are preferably linear in the Ri group (i.e. there are no side chain groups). Ri group is preferably aliphatic and does not contain rings.
  • the Ri group may by optionally substituted, e.g. carry up to three
  • substituents e.g. selected from halo, Ci_ 6 alkyl e.g. methyl, Ci_ 6 alkoxy. If present the substituents are preferably non-polar, and small, e.g. a methyl group. It is preferred however, if the Ri group remains unsubstituted.
  • the Ri group is preferably linear, i.e. there are no branches in the Ri chain.
  • the Ri group may derive from arachidonic acid, docosahexaenoic acid or eicosapentaenoic acid.
  • the polyunsaturated ester is of formula (VI):
  • R 6 is a C1-C4 alkyl group.
  • R 6 may be methyl, ethyl, n-propyl, i-propyl, n-buyl, 2- methyl propyl, 3-methyl propyl or tert-butyl.
  • R 6 is ethyl.
  • the polyunsaturated ester is hydrolysed in the presence of an aqueous base in a mixture of lower alcohol and water, wherein the term lower alcohol means a C1-C4 alcohol group.
  • the alkyl portion may be methyl, ethyl, n-propyl, i-propyl, n- butyl, 2-methyl propyl, 3-methyl propyl or tert-butyl.
  • the alcohol is methanol or ethanol.
  • solvents lower alcohol and H 2 0 form 90-100 vol% of the solvent in step a-i), preferably 95-100 vol%, preferably 98-100 vol%.
  • the ratio of lower alcohol to water (vol/vol) in step a-i) is preferably 50:50 to 90:10, preferably 55:45 to 85:15, more preferably 60:40 to 80:20. Ratios of 65:35 to 75:25 are particularly suitable.
  • Any suitable base may be used, such as a metal carbonate, a metal hydrogen carbonate or a metal hydroxide, especially alkali metal carbonates or alkali metal hydrogen carbonates, or alkali metal hydroxides.
  • Suitable bases include the carbonates, hydrogen carbonates or hydroxides of Li, Na, K, Rb or Cs.
  • particularly preferred base is LiOH.
  • step a-i is heated, e.g. to 20 to lOO’C, such as 50 to 90°C, e.g. under reflux.
  • suitable conditions include LiOH as base in a mixture of EtOH/H 2 0.
  • suitable conditions include LiOH as base in a mixture of MeOH/H 2 0.
  • Step a-i) involves hydrolysis of the ester unit, e.g. the -CO2R6 unit within the polyunsaturated ester, such as a compound of formula (G) or (VI).
  • the reaction mixture will typically be acidified, e.g. to a pH of ⁇ 5 to neutralize the base, e.g. by addition of aqueous acid.
  • an acidified alcohol could be used.
  • methanolic HC1 could be used if step a-i) has been carried out in MeOH/H 2 0.
  • the alcohol used in any acidified alcohol is ideally the same as the alcohol used as the solvent.
  • the solvent mixture may be adjusted before carrying out step a-ii), e.g. by removing a portion (but not all) of the lower alcohol/H 2 0 solvent, or addition of more lower alcohol and/or more H 2 0. Preferably however, there is no removal of solvent. It will be appreciated that the alcohol to water solvent ratio may change as the addition of alcoholic acid changes the ratio.
  • step (a-i) it is a preferred feature of the present invention that no purification steps (besides adjustment of pH or adjustment of solvent content) are carried out between steps a-i) and a-ii).
  • the process steps (a-i) to (a-iii) proceed without purification by chromatography and/or distillation between steps.
  • the reaction mixture is taken directly from substrate ester to product epoxide.
  • no aqueous or organic washes need to be carried out. There is ideally no work up therefore.
  • no purification of the polyunsaturated acid is carried out before the next step.
  • the mixture from step a-i) is preferably a “crude mixture”.
  • Step a-ii) - Halolactonization
  • the mixture of polyunsaturated acid formed in step a-i) is treated with a reagent to effect halolactonization of the acid (halolactonization agent). This is preferably carried out in the same vessel as step a-i).
  • halolactonization An exemplary reagent is I 2 , which is typically added as a mixture of I 2 , KI and NaHCCb.
  • Other suitable reagents include N-halo compounds, such as N-bromosuccinimide and N-bromo-phthalimide.
  • the halolactonization agent should be in molar excess relative to the amount of polyunsaturated ester inputted to step a-i) (to ensure conversion to the halolactone).
  • the molar equivalents of halolactonization agent relative to the amount of polyunsaturated acid may be between 1.05 to 1.5 mol, particularly where I 2 is used.
  • the ratio of lower alcohokfhO (vokvol) in step a-ii) is preferably 50:50 to 90:10, preferably 55:45 to 85:15, more preferably 60:40 to 80:20. Ratios of 65:35 to 75:25 are particularly suitable.
  • halolactonization step a-ii) will depend in part on the solvent mixture present in step a-ii).
  • the lower alcohol solvent used in a-ii) is the same as the lower alcohol used is step a-i).
  • EtOH/fbO iodolactonization using I2, KI and NaHC0 3 .
  • MeOH/fbO is used as solvent, using I2, KI and NaHC0 3 .
  • the use of methanol typically leads to a faster reaction.
  • step a-ii is heated, e.g. to 20 to lOO’C, such as 50 to 90°C, e.g. under reflux.
  • the iodolactone is not isolated but is believed to have the structure:
  • iodolactones are useful intermediates in a variety of chemical products such as prostaglandins.
  • the techniques discussed herein could therefore be useful in the synthesis of other products.
  • the one vessel preparation of an iodolactone from the corresponding alkyl ester is an interesting reaction in chemical synthesis.
  • the invention provides a process comprising the steps of:
  • R20 is lower alkyl
  • R21 is H or substituted or unsubstituted hydrocarbyl
  • R22 is H or substituted or unsubstituted hydrocarbyl
  • R23 is H or substituted or unsubstituted hydrocarbyl
  • step a-iii) of a process according to the present invention the halolactone product formed in step a-ii) is treated with a reagent/reagents to effect opening of the halolactone with formation of an epoxide. It is preferred that the reagent/reagents are added straight to the crude mixture from step a-ii). This step is preferably carried out therefore in the same vessel as step a-i) and a-ii).
  • a particularly suitable reagent is a carbonate, e.g. metal carbonate such as potassium carbonate.
  • Na 2 S 2 0 3 , and NaHCCh can be used to work up the process.
  • step a-iii) It is possible to adjust the solvent content before carrying out step a-iii). This may be achieved by removing a portion of the lower alcohol/water solvent or, preferably, by addition of more lower alcohol and/or H 2 0.
  • the lower alcohol used in step a-iii) is the same as that used in steps a-i) and a-ii). It is required therefore that the solvent in all three steps a-i) to a-iii) comprises the same lower alcohol.
  • the inventors have established that if a mixture of MeOH/H 2 0 is used in steps a-i) and a-ii), then it may be preferable to increase the increase the proportion of MeOH in the solvent mixture in step a-iii). This can be achieved by adding additional MeOH to the mixture formed at the end of step a-ii) before adding the reagents for step a-iii).
  • solvents lower alcohol and H 2 0 form 90-100 vol% of the solvent in step a-iii), preferably 95-100 vol%, preferably 98-100 vol%.
  • the ratio of lower alcohol:H 2 0 (vohvol) in step a-iii) is preferably 50:50 to 90:10, preferably 55:45 to 85:15, more preferably 60:40 to 80:20. Ratios of 65:35 to 75:25 are particularly suitable.
  • the epoxide that forms is preferably of formula
  • Each of steps a-i) to a-iii) may independently be effected at a temperature of 20 to 1 l0°C, such as 25 to l00°C.
  • a particularly preferred range is 50 to 90°C such as 55 to 80°C, e.g. about 60°C.
  • the temperature of all three steps a-i) to a-iii) is about the same and the temperature of the reaction can be kept constant over the three reactions.
  • the inventors therefore demonstrate that the ester can be converted to the epoxide in a one pot reaction.
  • the inventors have surprisingly established that the purity of epoxide product formed after step a-iii) (crude material as measured by 1 H NMR) is comparable to that formed when work-up steps are included after steps a-i) and a-ii). It was an unexpected advantage that a one-pot approach is feasible given the complex chemistries involved and propensities to make unwanted side products.
  • the crude epoxide product after work-up of step a-iii may be appropriate to purify the crude epoxide product after work-up of step a-iii), typically by chromatographic purification.
  • the purity of the epoxide may be 70 to 100%, such as 80 to 100%, especially 90 to 100% as judged by chromatography.
  • the crude product from step a-iii) can be used crude in subsequent steps, e.g. to prepare the polyunsaturated ketone using chemistry described in W02015/011206 and WO2016/116634.
  • Such a work-up procedure may include removing solvent from the crude mixture formed in step a-iii) and may also include aqueous/organic extraction.
  • the polyunsaturated ester is of formula
  • R 6 is a C1-C4 alkyl group is converted to an epoxide of formula
  • step b Aldehyde Formation
  • the polyunsaturated epoxide of the invention can be converted to its corresponding polyunsaturated aldehyde and then to a polyunsaturated alcohol following published protocols.
  • the polyunsaturated aldehyde that is formed is of formula RiCHO where Ri is as hereinbefore defined.
  • the polyunsaturated epoxide may be formed by the methods described for steps a-i) to a-iii) and may have been purified following step a-iii), or may be used crude following step a-iii).
  • step b) Suitable chemistry for step b) has been previously described in W02015/011206 and WO2016/116634 (NaI04/Me0H/H20), and in Flock et al.
  • step b) is carried out by treatment of the epoxide with an excess of H5IO6.
  • H5IO6 Sodium periodate or hydrogen peroxide could also be used.
  • a typical excess is 1.5 to 3 molar equivalents of H 5 IO 6 , especially 2 ⁇ 0.5 equivalents.
  • an aldehyde can be prepared via the dialkylacetal in an alcohol solvent with formic acid work up.
  • step b) is carried out in a mixed solvent of THF/Et20.
  • Suitable volume ratios range from 1 :3 to 3:1.
  • the aldehyde and reagent e.g. H5IO6
  • Any solvent is preferably anhydrous.
  • step (b) follows step (a-iii) without purification of the (a-iii) product, i.e. steps a-i to (b) can be carried out in one pot.
  • the aldehyde RiCHO or more preferably the compound (X) may be used in step (d) below. However, before reduction, an isomerisation reaction can be effected. In a preferred embodiment, an aldehyde of formula X can be isomerized to an aldehyde of formula XI:
  • step c) will involve treating the aldehyde with an amine base in slightly polar solvents.
  • Typical amine bases include 1,8- Diazabicyclo[5.4.0]undec-7-ene (DBU) and l,5-Diazabicyclo[4.3.0]non-5-ene (DBN).
  • Typical solvents are THF or ether.
  • steps b) and c may include aqueous/organic extraction.
  • the solvent may also be changed between steps b) and c).
  • typically no purification e.g. chromatography occurs between steps b) and c).
  • Step d) - alcohol formation The invention further comprises therefore conversion of a compound of the polyunsaturated aldehyde, e.g. RiCHO to R1CH2-OH;
  • R 1 is as hereinbefore defined.
  • DIBAH diisobutylaluminium hydride
  • an aldehyde of formula (X) or (XI) is treated with a reducing agent to form an alcohol of formula (XII) or (XIII)
  • the invention relates to the conversion of a
  • R 2 is a Ci -20 hydrocarbyl group, preferably Ci-io hydrocarbyl group, especially Ci-io alkyl group, such as Ci -4 alkyl group, especially methyl.
  • R 2 is preferably a linear Ci -20 hydrocarbyl group such as linear Ci-io alkyl group.
  • the halide (hal) can be F, Cl, Br or I, especially Br or Cl, most especially Cl.
  • the reaction of the polyunsaturated alcohol with the sulphonyl halide is preferably effected in the presence of a base, ideally to neutralise any halide acids (e.g. HC1) that form during the reaction.
  • a base ideally to neutralise any halide acids (e.g. HC1) that form during the reaction.
  • the base should not itself react with the polyunsaturated compounds.
  • Suitable bases are well known in the art, such as trialkylamines, in particular triethylamine. Well known non nucleophilic bases are therefore appropriate.
  • the starting material is preferably R I CH 2 OH (XV), especially compounds (XII) or (XIV).
  • Step (f) of the process of the invention requires the conversion of the sulphonyl ester (XVI) into a polyunsaturated thioester.
  • R 4 is a Ci -20 hydrocarbyl group.
  • the counterion can be a metal such as an alkali metal, e.g. Li, Na or K.
  • R4 is preferably a Ci-io hydrocarbyl group, especially a Ci-io alkyl group, such as Ci -6 alkyl group especially Ci -4 alkyl group such as methyl. Any R4 group is preferably linear. The use of a thioacetate ion is preferred.
  • steps e) and f) involve the conversion of an alcohol of formula XIII or (XIV):
  • R 4 is as hereinbefore defined.
  • Step e) and f) are preferably carried out in the same solvent.
  • the crude product will be purified following completion of step f).
  • the crude thioester product after work-up of step f may be appropriate to purify the crude thioester product after work-up of step f), typically by chromatographic purification.
  • the purity of the thioester may be 70 to 100%, such as 80 to 100%, especially 90 to 100% as judged by chromatography.
  • the first and second embodiments discussed above produce intermediate compounds that are useful in the formation of certain target compounds such as compounds A and B identified above.
  • the remaining steps required to convert the product of step (f) to the target compounds of the invention are known.
  • Target compounds of the invention are those of formula R 1 CH 2 -S- CH 2 COCF 3 where Ri is as hereinbefore defined.
  • the invention provides a method of producing a pharmaceutically acceptable 1,1,1 -trifluoro-3-(((2E,6Z,9Z, 12Z, 15Z,)-octadeca- 2 , 6 , 9 , 12 , 15 -p entaein- 1 -y l)thio)prop an-2 -one :
  • step (g) of the process To prepare these compounds, in step (g) of the process
  • a thiocarboxylate is deprotected to provide a thiol.
  • Deprotection may be by any means suitable, which include reaction with a base in an alcoholic solvent, such as potassium carbonate in methanol.
  • step g) is carried out in the presence of an antioxidant to prevent formation of the thiol.
  • a preferred antioxidant is a-tocopherol.
  • step g) The crude product from step g) is preferably used in step h) without purification.
  • the last step of the process of the invention therefore involves reaction of the thiol with a suitable ketone to form the desired compounds.
  • the reaction preferably involves a compound is of formula (LG)CH 2 CO-X i.e.
  • LG represents a leaving group which is nucleophilicly substituted by the thiol group.
  • the reagent is LG-CH 2 -COX, where LG is a leaving group such as a halide, tosyl, mesyl and so on.
  • LG is a halide such as Br.
  • X is preferably CF3.
  • (LG)R 3 -COX is BrCH 2 -COCF3.
  • This final reaction step may take place in the presence of anti-oxidant as hereinbefore defined.
  • tocopherol is especially preferred, particularly (+/- )-alpha-tocopherol.
  • the invention comprises a process comprising steps a-i) to a-iii) as herein defined and the subsequent conversion of the epoxide lower alkyl ester to the target compounds such R 1 CH 2 -S-CH 2 COCF 3 where Ri is as hereinbefore defined;
  • the invention covers a process in which steps (e) and (f) as hereinbefore defined are carried out and the product thioester is converted to the target compounds such R 1 CH 2 -S-CH 2 COCF 3 where Ri is as hereinbefore defined;
  • the invention provides a process comprising steps (a-i) to (a-iii) as hereinbefore defined, conversion of the epoxide to the corresponding alcohol (steps b-d), followed by steps (e) and (f) as hereinbefore defined and conversion of the thioester to the target compounds such RiCFb-S- CH2COCF3 where Ri is as hereinbefore defined;
  • Steps a-i to a-iii and (e)-(f) are carried out in one pot as herein defined.
  • the invention will now be described with reference to the following non limiting examples and figures.
  • Figure 4a HPLC of crude epoxide after step a-iii) on 200 g scale.
  • Figure 4b 1H NMR of crude epoxide after step a-iii) on 200 g scale.
  • Example 1 One-pot Synthesis of Methyl 3-(3-((2Z,5Z,8Z,l lZ,14Z)-heptadeca- 2,5,8,ll,14-pentaen-l-yl)oxiran-2-yl)propanoate
  • Example 3 One pot conversion of polyunsaturated alcohol to thioester

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A process comprising the following steps: a-i) treating a polyunsaturated ester with a base in a solvent of lower alcohol and water to form the corresponding polyunsaturated acid; a-ii) treating the product from step a-i), especially the crude product, with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone; and a-iii) treating the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol and water to convert the polyunsaturated halolactone to the corresponding polyunsaturated epoxide lower alkyl ester.

Description

Processes in the preparation of polyunsaturated ketone compounds Field of the Invention
This invention relates to a method of making a polyunsaturated epoxide compound and optional subsequent conversion of that epoxide compound into a polyunsaturated ketone. In particular, the invention relates to the conversion of a polyunsaturated ester to a polyunsaturated epoxide compound in a single vessel or “pot”. The polyunsaturated epoxide is an intermediate that can then be converted to a polyunsaturated ketone thus enabling the formation of that ketone in fewer steps. The invention significantly reduces or in preferred cases avoids separate work up procedures and thus simplifies the process without a significant reduction in overall yield or purity.
In a second embodiment, the invention relates to the conversion of a polyunsaturated alcohol to a polyunsaturated thioester and optional subsequent conversion of that thioester into a polyunsaturated ketone. In particular, the invention relates to the conversion of a polyunsaturated alcohol to a polyunsaturated thioester compound in a single vessel or pot. That polyunsaturated thioester can then be converted to a polyunsaturated ketone thus enabling the formation of that ketone in fewer steps. The invention significantly reduces or in preferred cases avoids separate work up procedures and thus simplifies the process without a significant reduction in overall yield or purity. Background
There have been reports that certain polyunsaturated trifluoromethyl ketone compounds have useful biological activities. See, for example, U.S Pat. No.
7,687,543; Huwiler, A et al. (2012) Br. J. Pharm. 167: 1691.
Methods for preparing particular polyunsaturated ketones have been disclosed. In one method disclosing the synthesis of particular polyunsaturated trifluoromethyl ketones, a Mitsunobu-type reaction was used to transform an alcohol to the corresponding thioester. Further chemical reactions were said to produce the polyunsaturatcd trifluoromethyl ketone (compound 18 therein) in 71% yield. See Holmeide, A and L. Skattebol (2000) J. Chem. Soc. Perkin Trans. 1 : 2271. In WO2016/116334 the manufacture of a polyunsaturated thiol and eventually a corresponding polyunsaturated ketone is described.
While such synthetic methods have been useful for some applications, there is a need for more efficient and cost-effective methods for making such compounds. In particular, the process for making the target compounds would be more attractive if fewer synthetic steps were involved.
Accordingly, the present inventors sought a process for the manufacture of a polyunsaturated ketone compound that requires fewer steps without a significant reduction in overall yield or purity.
The present invention relates to the manufacture of certain intermediates useful in the manufacture of the target compounds as well as an overall process for the preparation of the compounds of the invention.
After extensive synthetic work, the inventors have determined that particular processes as claimed herein offer an ideal route to the compounds of the invention as the processes use a single pot without separate work up procedures to reduce the number of steps in the process. The process described herein not only achieves very high purity but achieves very high yield. It can also be readily scaled up to industrial operation. As the process uses fewer steps, the overall process is cheaper and faster.
Moreover, the fact that the reactions detailed herein can be carried out in a single pot is remarkable. The inventors anticipated that combining the reactions into a single step would result in the formation of numerous side products. Surprisingly, this has not occurred. It is also surprising that the reactions defined in the first embodiment can be effected in the same solvent.
Summary of invention
The present inventors have found that a polyunsaturated ester can be converted to a polyunsaturated epoxide in a single reaction vessel or pot. The chemistry described herein avoids or at least reduces the formation of side products and enables the formation of a polyunsaturated epoxide and eventually a
polyunsaturated thiol which can be used in further synthetic steps to form desired target polyunsaturated ketone molecules.
It is therefore an object of the invention to prepare polyunsaturated epoxide compounds in a single pot. Such polyunsaturated epoxide compounds can ultimately be converted to the advantageous compounds such as the polyunsaturated ketone compounds discussed herein.
The method of the invention involves a single step process comprising hydrolysis and then halolactonisation of a polyunsaturated ester and conversion to the corresponding polyunsaturated epoxide. That epoxide can be reduced to a polyunsaturated aldehyde and then polyunsaturated alcohol. The alcohol can be converted to a thioester (of formula -SCOR4 wherein R4 is a Ci-20 hydrocarbyl group) in one pot, with subsequent conversion of the thioester to desired target compounds.
Thus, viewed from one aspect the invention provides a process comprising the steps of:
(a) combining, in a vessel, a polyunsaturated ester and a halolactonization agent in a solvent of lower alcohol and water to form a mixture,
(ab) treating, e.g. heating, the mixture in the presence of a reagent and under conditions sufficient to form a polyunsaturated epoxide lower alkyl ester in the vessel.
Viewed from another aspect the invention provides a process comprising the following steps:
a-i) treating a polyunsaturated ester with a base in a solvent of lower alcohol and water to form the corresponding polyunsaturated acid;
a-ii) treating the product from step a-i), especially the crude product, with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone; and
a-iii) treating the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol and water to convert the polyunsaturated halolactone to the corresponding polyunsaturated epoxide lower alkyl ester It is particularly preferred if steps a-i) to a-iii) are carried out in the same reaction vessel.
Viewed from another aspect the invention provides a process comprising the following steps:
a-i) treating in a vessel a polyunsaturated ester with a base in a solvent of lower alcohol and water to form the corresponding polyunsaturated acid;
a-ii) treating in the vessel the product from step a-i), especially the crude product, with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone; and
a-iii) treating in the vessel the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol and water to convert the polyunsaturated halolactone to the corresponding polyunsaturated epoxide lower alkyl ester.
Viewed from another aspect the invention provides a process comprising the following steps:
(a-i) treating a polyunsaturated alkyl ester of formula (F) RI-CH=CH-CH2CH2COOR6 (F) such as the compound
Figure imgf000005_0001
wherein R1 is an optionally substituted CY22 unsaturated hydrocarbon group, said hydrocarbon group comprising at least 2, preferably at least 4 double bonds; and R6 is a C1-C4 alkyl group;
with a base in a solvent of lower alcohol/water to form the corresponding polyunsaturated acid of formula (IF):
RI-CH=CH-CH2CH2COOH (IF) such as the compound
Figure imgf000006_0001
wherein Ri is as hereinbefore defined;
a-ii) treating the product from step a-i), especially the crude product, with a iodolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone compound
Figure imgf000006_0002
wherein Ri is as hereinbefore defined; and
a-iii) treating the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol/water to convert the iodolactone to the corresponding polyunsaturated epoxide lower alkyl ester of formula (IV):
Figure imgf000006_0003
wherein Ri is as hereinbefore defined and Rs is Ci-4alkyL It is particularly preferred if steps (a-i) to (a-iii) are carried out in the same reaction vessel.
Viewed from another aspect the invention provides a process comprising the following steps:
a-i) treating a polyunsaturated alkyl ester of formula (VI):
Figure imgf000007_0001
wherein R6 is a C1-C4 alkyl group;
with a base in a solvent of lower alcohol and water to form the corresponding polyunsaturated acid;
a-ii) treating the product from step a-i), especially the crude product, with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding halolactone; and
a-iii) treating the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol and water to convert the halolactone to the corresponding epoxide of formula (IX):
Figure imgf000007_0002
wherein R5 is Ci-4alkyL
It is particularly preferred if steps (a-i) to (a-iii) are carried out in the same reaction vessel.
Viewed from another aspect the invention provides a process for the preparation of a polyunsaturated thioester comprising:
(e) reacting a polyunsaturated alcohol in the presence of a compound of formula R2-S02Hal wherein R2 is a Ci_2o hydrocarbyl group, such an Ci_io alkyl group, to form a polyunsaturated sulphonyl ester;
(f) converting the polyunsaturated sulphonyl ester to a polyunsaturated thioester by reacting with an anion of formula SC(=0)R4 wherein R4 is a Ci_2o hydrocarbyl group;
wherein steps (e) and (f) are carried out sequentially or preferably consecutively in one vessel. It is preferred if the same solvent is used in steps (e) and (f). It is preferred if there are no work up procedures between step (e) and (f). Ideally, the anion of formula SC(=0)R4 is added to the crude product of step (e). Viewed from another aspect the invention provides a process including at least the following steps:
(e) reacting a polyunsaturated alcohol of formula (XV) R1CH2OH (XV) wherein R1 is an optionally substituted CY22 unsaturated hydrocarbon group, said hydrocarbon group comprising at least 2, preferably at least 4 double bonds; in the presence of a compound of formula R2-S02Hal wherein R2 is a Ci-20 hydrocarbyl group, such an Ci-io alkyl group, to form a polyunsaturated sulphonyl ester of formula (XVI)
RICH20S02R2 (XVI); (f) converting the polyunsaturated sulphonyl ester of formula (XVI) to a polyunsaturated thioester (XVII)
RICH2SC(=0)R4 (XVII) by reacting with an anion of formula SC(=0)R4 wherein R4 is a Ci-20 hydrocarbyl group;
wherein steps (e) and (f) are carried out consecutively in one vessel.
Viewed from another aspect the invention provides a process including at least the following steps:
(e) reacting (3Z,6Z,9Z,l2Z,l5Z)-octadeca-3,6,9,l2,l5-pentaen-l-ol
Figure imgf000008_0001
or (2E,6Z,9Z, 12Z, 15Z,)-octadeca-2,6,9, 12, 15-pentaen- 1 -ol;
Figure imgf000009_0001
with methanesulphonyl chloride in the presence of a base so as to form a
Figure imgf000009_0002
(f) reacting the reaction product of step (e) with a thioacetate ion to form a thioester of formula:
Figure imgf000009_0003
wherein steps (e) and (f) are carried out consecutively in one vessel.
In one embodiment (step g), the product of step (f) is reacted with a metal carbonate in the presence of an antioxidant to form a thiol of formula:
Figure imgf000010_0001
In one embodiment, the thiol produced in step (g) is reacted with 3- bromo-l,l,l-trifluoroacetone under conditions that produce compounds A or B:
Figure imgf000010_0002
where X is CF3.
Definitions
The term polyunsaturated in the term polyunsaturated thiol or
polyunsaturated ester and so on refers to compounds which contains a hydrocarbon chain containing multiple double bonds, i.e. 2 or more. That chain is preferably free of any rings. It is preferred if double bonds present are not conjugated. The chain is preferably aliphatic. In any polyunsaturated ester group, it is preferred if there is a double bond gamma to the carbonyl in order to enable the formation of the halolactone.
Any polyunsaturated ester is preferably a lower alkyl ester.
The term acid typically refers to a carboxylic acid unless context permits. The term Hal means halide, i.e. F, Cl, Br or I.
The term Ci-20 hydrocarbyl group refers to a group containing 1 to 20 carbon atoms and H atoms only. The group may be a Ci-io hydrocarbyl group, such as a Ci-10 alkyl group, C2-10 alkenyl, C6-io aryl group, C7_io alkylaryl, C7_ioarylalkyl group, C3-io-cycloalkyl group, C4-ioalkylcycloalkyl or C4-iocycloalkylalkyl group and so on. As long as there are only C and H atoms present and up to 20 carbon atoms, any arrangement of those atoms is possible. Any hydrocarbyl group is preferably a Ci_ loalkyl group. Any hydrocarbyl group is preferably a linear Ci-ioalkyl group.
Generally, any polyunsaturated compound of the invention will have an Mw of less than 500 g/mol, preferably 450 g/mol or less, more preferably 400 g/mol or less.
The term "pharmaceutically acceptable" means that which is useful in preparing a pharmaceutical that is generally non-toxic and is not biologically undesirable and includes that which is acceptable for veterinary use and/or human pharmaceutical use.
The term lower alcohol means a Cl -4 alcohol such as methanol or ethanol. The term lower alkyl means a Cl -4 alkyl.
Detailed Description of Invention
This invention generally relates to processes useful in the preparation of certain polyunsaturated ketone compounds, e.g. of formula R1CH2-SCH2COCF3, in particular compounds A and B below.
Figure imgf000011_0001
Compound B
Figure imgf000011_0002
Compound A where X is CF3.
In a first embodiment, this invention particularly relates to a process for the manufacture of a polyunsaturated epoxide that is a useful intermediate in the synthesis of these compounds. The process offers high yields and high purity but uses fewer separate steps than are used in prior art processes. Remarkably, despite fewer steps, there is no significant loss of purity or yield. The process can also be readily scaled up for industrial operation.
In a first embodiment therefore, the invention provides a way of making a polyunsaturated epoxide intermediate. In other embodiments, the invention relates to the subsequent conversion of that polyunsaturated epoxide to a polyunsaturated thioester, then to a polyunsaturated thiol and then to a polyunsaturated ketone.
In a second embodiment, the invention relates to the preparation of a polyunsaturated thioester intermediate useful in the formation of compounds like compounds A and B above. The polyunsaturated thioester is obtained from a polyunsaturated alcohol in high yield and purity and preferably without any inter step purification. The combination of embodiments one and two forms a still yet further aspect of the invention.
WO2015/011206 (PCT/EP2014/065853) and WO2016/116634 (PCT/EP2016/051456) describe a process in which a polyunsaturated ester is converted, via an epoxide to a polyunsaturated ketone (Scheme 1).
Figure imgf000012_0001
Scheme 1 In order to prepare the epoxide, the necessary steps are a-i), a-ii) and a-iii).
These represent a sequence of hydrolysis (a-i), halolactonization (a-ii) and epoxide formation (a-iii).
In W02015/011206 (PCT/EP2014/065853), the hydrolysis step is performed using LiOH in EtOH/H20, while iodolactonization is performed in THF/water and the epoxide formation takes place in MeOH (leading therefore to the formation of a methyl ester). There is a work-up step after each one of steps a-i), a-ii) and a-iii).
The use of a different solvent system in each step requires solvent removal and new solvent addition between steps. The intermediate acid and lactone are therefore purified during the prior art procedure. This has the downside that the method is made more complex by the need to remove and add solvent, and is made more expensive by the need for fresh solvent in each step.
WO2016/116634 also describes step a-i) being carried out in EtOH/H20. A solvent change is needed in step a-ii) where THF/H20 is used. Step a-iii) is then carried out in MeOH.
The inventors have now surprisingly established that it is possible to carry out the hydrolysis, halolactonization and epoxidation steps without a change of solvent between each step. The inventors have surprisingly established that it is possible to carry out steps a-i) to a-iii) using a mixture of lower alcohol/H20 in each of the steps. This is surprising because until now it was thought that different solvents were needed for each of steps a-i) to a-iii). Furthermore, it is possible to carry out this sequence of reactions without detriment to epoxide purity or yield.
This is highly surprising given the complex chemistry involved and the potential for the formation of side-reactions in steps a-i) to a-iii).
Moreover, it is preferred if steps a-i) to a-iii) are carried out without any organic and/or aqueous washing steps between steps a-i) and a-ii) and a-ii) to a-iii).
Moreover, it is also preferred if there is no requirement to remove any reactant from an earlier step before carrying out a subsequent step although it may be necessary to quench the reaction mixture.
In a most preferred embedment therefore, steps a-i) to a-iii) are carried out in one pot using the same solvent and ideally without any work up procedures between the steps.
Embodiment 1
Step a-i) - Ester hydrolysis
The starting material in the process of the invention is a polyunsaturated ester. Preferably that polyunsaturated alcohol is of formula (G):
RI-CH=CH-CH2CH2COOR6 ( ) wherein Ri is an optionally substituted CY22 unsaturated hydrocarbon group, said hydrocarbon group comprising at least 2, preferably at least 4 double bonds; and R6 is a C1-C4 alkyl group. The double bond in formula (G) is preferably in cis thus making the compound formula (I):
Figure imgf000014_0001
In any embodiment of the invention, it is preferred if in any group Ri, double bonds are not conjugated. The group Ri preferably comprises 5 to 9 double bonds, preferably 5 or 8 double bonds, e.g. 5 to 7 double bonds such as 5 or 6 double bonds.
It is also preferred if the double bonds do not conjugate with the double bond depicted in formula (G).
The double bonds present in the group Ri may be in the cis or trans configuration however, it is preferred if the majority of the double bonds present (i.e. at least 50%) are in the cis configuration. In further advantageous embodiments all the double bonds in the group Ri are in the cis configuration or all double bonds are in the cis configuration except the double bond nearest the -CH=CH- CH2CH2COOR6 group which may be in the trans configuration.
The group Ri may have between 8 and 22 carbon atoms, preferably 10 to 19 carbon atoms, especially 16 to 18 carbon atoms. Carbon atoms are preferably linear in the Ri group (i.e. there are no side chain groups). Ri group is preferably aliphatic and does not contain rings.
The Ri group may by optionally substituted, e.g. carry up to three
substituents, e.g. selected from halo, Ci_6 alkyl e.g. methyl, Ci_6 alkoxy. If present the substituents are preferably non-polar, and small, e.g. a methyl group. It is preferred however, if the Ri group remains unsubstituted.
The Ri group is preferably linear, i.e. there are no branches in the Ri chain.
It preferably derives from a natural source such as a long chain fatty acid or ester. In particular, the Ri group may derive from arachidonic acid, docosahexaenoic acid or eicosapentaenoic acid.
It is thus preferred if the polyunsaturated ester is a compound of formula (I”) Rr-CH=CH-CH2CH2COOR6 (I”) wherein Rr is a linear, unsubstituted Ci4-22 unsaturated aliphatic hydrocarbon group, said hydrocarbon group comprising at least 4 double bonds.
In a preferred embodiment, the polyunsaturated ester is of formula (VI):
Figure imgf000015_0001
wherein R6 is a C1-C4 alkyl group.
In any embodiment, R6 may be methyl, ethyl, n-propyl, i-propyl, n-buyl, 2- methyl propyl, 3-methyl propyl or tert-butyl. Preferably R6 is ethyl.
The polyunsaturated ester is hydrolysed in the presence of an aqueous base in a mixture of lower alcohol and water, wherein the term lower alcohol means a C1-C4 alcohol group. The alkyl portion may be methyl, ethyl, n-propyl, i-propyl, n- butyl, 2-methyl propyl, 3-methyl propyl or tert-butyl. Preferably the alcohol is methanol or ethanol.
Preferably together solvents lower alcohol and H20 form 90-100 vol% of the solvent in step a-i), preferably 95-100 vol%, preferably 98-100 vol%.
The ratio of lower alcohol to water (vol/vol) in step a-i) is preferably 50:50 to 90:10, preferably 55:45 to 85:15, more preferably 60:40 to 80:20. Ratios of 65:35 to 75:25 are particularly suitable.
Any suitable base may be used, such as a metal carbonate, a metal hydrogen carbonate or a metal hydroxide, especially alkali metal carbonates or alkali metal hydrogen carbonates, or alkali metal hydroxides. Suitable bases include the carbonates, hydrogen carbonates or hydroxides of Li, Na, K, Rb or Cs. A
particularly preferred base is LiOH.
The skilled person will readily be able to determine suitable conditions (concentration, temperature and time) for step a-i). It is preferred if step a-i) is heated, e.g. to 20 to lOO’C, such as 50 to 90°C, e.g. under reflux. By way of example only, suitable conditions include LiOH as base in a mixture of EtOH/H20. As a further example, suitable conditions include LiOH as base in a mixture of MeOH/H20.
Step a-i) involves hydrolysis of the ester unit, e.g. the -CO2R6 unit within the polyunsaturated ester, such as a compound of formula (G) or (VI). Once the hydrolysis is completed (which may be determined by routine methods known in the art) the reaction mixture will typically be acidified, e.g. to a pH of ~5 to neutralize the base, e.g. by addition of aqueous acid. Alternatively, an acidified alcohol could be used. For instance, methanolic HC1 could be used if step a-i) has been carried out in MeOH/H20. The alcohol used in any acidified alcohol is ideally the same as the alcohol used as the solvent.
In some embodiments the solvent mixture may be adjusted before carrying out step a-ii), e.g. by removing a portion (but not all) of the lower alcohol/H20 solvent, or addition of more lower alcohol and/or more H20. Preferably however, there is no removal of solvent. It will be appreciated that the alcohol to water solvent ratio may change as the addition of alcoholic acid changes the ratio.
It is a preferred feature of the present invention that no purification steps (besides adjustment of pH or adjustment of solvent content) are carried out between steps a-i) and a-ii). In one embodiment therefore, the process steps (a-i) to (a-iii) proceed without purification by chromatography and/or distillation between steps. Ideally, the reaction mixture is taken directly from substrate ester to product epoxide. Importantly, no aqueous or organic washes need to be carried out. There is ideally no work up therefore. Preferably therefore, no purification of the polyunsaturated acid is carried out before the next step. The mixture from step a-i) is preferably a “crude mixture”. The product of step (a-i) is therefore a polyunsaturated acid, such as RI-CH=CH-CH2CH2COOH, especially the acid of formula VII
Figure imgf000016_0001
Step a-ii) - Halolactonization In a second step a-ii) of a process according to the present invention the mixture of polyunsaturated acid formed in step a-i) is treated with a reagent to effect halolactonization of the acid (halolactonization agent). This is preferably carried out in the same vessel as step a-i).
The skilled person will be aware of suitable reagents to effect
halolactonization. An exemplary reagent is I2, which is typically added as a mixture of I2, KI and NaHCCb. Other suitable reagents include N-halo compounds, such as N-bromosuccinimide and N-bromo-phthalimide.
Typically the halolactonization agent should be in molar excess relative to the amount of polyunsaturated ester inputted to step a-i) (to ensure conversion to the halolactone). The molar equivalents of halolactonization agent relative to the amount of polyunsaturated acid (assumed to be the same as the amount of polyunsaturated ester) may be between 1.05 to 1.5 mol, particularly where I2 is used.
Preferably lower alcohol and H2O together form 90-100 vol% of the solvent in step a-ii), preferably 95-100 vol%, preferably 98-100 vol%.
The ratio of lower alcohokfhO (vokvol) in step a-ii) is preferably 50:50 to 90:10, preferably 55:45 to 85:15, more preferably 60:40 to 80:20. Ratios of 65:35 to 75:25 are particularly suitable.
The conditions (concentration, temperature and time) used for the
halolactonization step a-ii) will depend in part on the solvent mixture present in step a-ii). The lower alcohol solvent used in a-ii) is the same as the lower alcohol used is step a-i).
One option is EtOH/fbO iodolactonization using I2, KI and NaHC03. In another option, MeOH/fbO is used as solvent, using I2, KI and NaHC03. The use of methanol typically leads to a faster reaction.
The use of lower alcohol/water as solvent in the halolactonization step significantly accelerated the iodolactonization procedure relative to the use of THF/water, which has previously been described as requiring 3 days for completion when carried out using I2, KI and NaHC03 in a mixture of THF/H2O (see W02015/011206). The skilled person will readily be able to determine suitable conditions (concentration, temperature and time) for step a-ii). It is preferred if step a-ii) is heated, e.g. to 20 to lOO’C, such as 50 to 90°C, e.g. under reflux.
It is a preferred feature of the present invention that no work-up (besides optional adjustment of solvent content or quenching of any residual iodolactonization agent) is carried out between steps a-ii) and a-iii). Importantly, it is preferred if there are no aqueous or organic washes are carried out. Preferably, no other purification of the halolactone is carried out.
The iodolactone is not isolated but is believed to have the structure:
Figure imgf000018_0001
The inventors have appreciated that iodolactones are useful intermediates in a variety of chemical products such as prostaglandins. The techniques discussed herein could therefore be useful in the synthesis of other products. In particular, the one vessel preparation of an iodolactone from the corresponding alkyl ester is an interesting reaction in chemical synthesis.
Thus, viewed from another aspect the invention provides a process comprising the steps of:
(a) hydrolysing, in a vessel, an ester of formula (XX)
Figure imgf000019_0001
wherein R20 is lower alkyl;
R21 is H or substituted or unsubstituted hydrocarbyl;
R22 is H or substituted or unsubstituted hydrocarbyl;
R23 is H or substituted or unsubstituted hydrocarbyl;
to the corresponding acid in a solvent of lower alcohol and water and adding an iodolactonization agent to form a mixture;
(b) treating, e.g. heating, the mixture under conditions sufficient to form the iodolactone in the vessel.
Step a-iii) - Epoxidation
In a third step a-iii) of a process according to the present invention the halolactone product formed in step a-ii) is treated with a reagent/reagents to effect opening of the halolactone with formation of an epoxide. It is preferred that the reagent/reagents are added straight to the crude mixture from step a-ii). This step is preferably carried out therefore in the same vessel as step a-i) and a-ii).
The skilled person will be aware of suitable reagents for converting halolactones into the corresponding epoxides with concomitant ring opening of the halolactone. A particularly suitable reagent is a carbonate, e.g. metal carbonate such as potassium carbonate. Na2S203, and NaHCCh can be used to work up the process.
It is possible to adjust the solvent content before carrying out step a-iii). This may be achieved by removing a portion of the lower alcohol/water solvent or, preferably, by addition of more lower alcohol and/or H20. The lower alcohol used in step a-iii) is the same as that used in steps a-i) and a-ii). It is required therefore that the solvent in all three steps a-i) to a-iii) comprises the same lower alcohol. The inventors have established that if a mixture of MeOH/H20 is used in steps a-i) and a-ii), then it may be preferable to increase the increase the proportion of MeOH in the solvent mixture in step a-iii). This can be achieved by adding additional MeOH to the mixture formed at the end of step a-ii) before adding the reagents for step a-iii).
Preferably together solvents lower alcohol and H20 form 90-100 vol% of the solvent in step a-iii), preferably 95-100 vol%, preferably 98-100 vol%.
The ratio of lower alcohol:H20 (vohvol) in step a-iii) is preferably 50:50 to 90:10, preferably 55:45 to 85:15, more preferably 60:40 to 80:20. Ratios of 65:35 to 75:25 are particularly suitable.
The epoxide that forms is preferably of formula
Figure imgf000020_0001
wherein Ri is as hereinbefore defined and Rs is Ci-4alkyl; especially of formula (IX):
Figure imgf000020_0002
Each of steps a-i) to a-iii) may independently be effected at a temperature of 20 to 1 l0°C, such as 25 to l00°C. A particularly preferred range is 50 to 90°C such as 55 to 80°C, e.g. about 60°C. In one embodiment, the temperature of all three steps a-i) to a-iii) is about the same and the temperature of the reaction can be kept constant over the three reactions.
The inventors therefore demonstrate that the ester can be converted to the epoxide in a one pot reaction. The inventors have surprisingly established that the purity of epoxide product formed after step a-iii) (crude material as measured by 1 H NMR) is comparable to that formed when work-up steps are included after steps a-i) and a-ii). It was an unexpected advantage that a one-pot approach is feasible given the complex chemistries involved and propensities to make unwanted side products.
In some embodiments it may be appropriate to purify the crude epoxide product after work-up of step a-iii), typically by chromatographic purification. The purity of the epoxide may be 70 to 100%, such as 80 to 100%, especially 90 to 100% as judged by chromatography.
In another aspect of the invention the crude product from step a-iii) can be used crude in subsequent steps, e.g. to prepare the polyunsaturated ketone using chemistry described in W02015/011206 and WO2016/116634.
It will typically be appropriate to carry out a work-up procedure after step a- iii) before conducting subsequent steps. Such a work-up procedure may include removing solvent from the crude mixture formed in step a-iii) and may also include aqueous/organic extraction.
It is thus preferred if the polyunsaturated ester is a compound of formula (G) RI-CH=CH-CH2CH2COOR6 (G) wherein Ri is a linear, unsubstituted CV22 unsaturated aliphatic hydrocarbon group, said hydrocarbon group comprising at least 2, preferably at least 4 double bonds; is converted to an epoxide of formula (IV)
Figure imgf000021_0001
wherein Ri and Rs are as hereinbefore defined in a one pot process especially without inter step purification.
In a more preferred embodiment, the polyunsaturated ester is of formula
(VI): /=\/=\/=\/NCo2Re
\=/\=/\=/\
(VI)
wherein R6 is a C1-C4 alkyl group is converted to an epoxide of formula
(ix);
Figure imgf000022_0001
wherein Rs is Ci_4alkyl;
in a one pot process especially without inter step purification. Aldehyde Formation (step b)
The polyunsaturated epoxide of the invention can be converted to its corresponding polyunsaturated aldehyde and then to a polyunsaturated alcohol following published protocols. Preferably the polyunsaturated aldehyde that is formed is of formula RiCHO where Ri is as hereinbefore defined.
It is preferred if a polyunsaturated epoxide of formula IX:
Figure imgf000022_0002
wherein Rs is Ci-4alkyl;
is treated with a reagent to produce an aldehyde of formula X:
Figure imgf000022_0003
The polyunsaturated epoxide may be formed by the methods described for steps a-i) to a-iii) and may have been purified following step a-iii), or may be used crude following step a-iii).
Suitable chemistry for step b) has been previously described in W02015/011206 and WO2016/116634 (NaI04/Me0H/H20), and in Flock et al.
Acta Chemica Scandinavia 54, 1999, 436-445.
In a preferred embodiment, step b) is carried out by treatment of the epoxide with an excess of H5IO6. Sodium periodate or hydrogen peroxide could also be used. A typical excess is 1.5 to 3 molar equivalents of H5IO6, especially 2 ± 0.5 equivalents. Alternatively, an aldehyde can be prepared via the dialkylacetal in an alcohol solvent with formic acid work up.
In a preferred embodiment step b) is carried out in a mixed solvent of THF/Et20. Suitable volume ratios range from 1 :3 to 3:1. It will be appreciated that the aldehyde and reagent (e.g. H5IO6) may initially be dissolved in separate solvents, with the mixed THF/Et20 solvent system only being formed upon mixture of the two. Any solvent is preferably anhydrous.
In one embodiment, step (b) follows step (a-iii) without purification of the (a-iii) product, i.e. steps a-i to (b) can be carried out in one pot. Optional Step c) Aldehyde isomerization
The aldehyde RiCHO or more preferably the compound (X) may be used in step (d) below. However, before reduction, an isomerisation reaction can be effected. In a preferred embodiment, an aldehyde of formula X can be isomerized to an aldehyde of formula XI:
Figure imgf000023_0001
Suitable reagents and conditions for achieving this are described in W02015/011206 (DBU/Et20). Typically step c) will involve treating the aldehyde with an amine base in slightly polar solvents. Typical amine bases include 1,8- Diazabicyclo[5.4.0]undec-7-ene (DBU) and l,5-Diazabicyclo[4.3.0]non-5-ene (DBN). Typical solvents are THF or ether.
Typically, a work-up procedure will be carried out between steps b) and c), which may include aqueous/organic extraction. The solvent may also be changed between steps b) and c). However, typically no purification (e.g. chromatography) occurs between steps b) and c).
Step d) - alcohol formation The invention further comprises therefore conversion of a compound of the polyunsaturated aldehyde, e.g. RiCHO to R1CH2-OH;
wherein R1 is as hereinbefore defined.
The use of diisobutylaluminium hydride (DIBAH) is particularly preferred in this regard. The present inventors have surprisingly found that some other well known reducing agents such as sodium borohydride cannot be used successfully in this reduction as they increase the number of impurities formed. It is surprising that the use of DIBAH seems to reduce isomerism and hence minimises impurity formation.
In a preferred step d), an aldehyde of formula (X) or (XI) is treated with a reducing agent to form an alcohol of formula (XII) or (XIII)
Figure imgf000024_0001
Second Embodiment - Thioester Formation
Step (e)
In a second aspect, the invention relates to the conversion of a
polyunsaturated alcohol to a polyunsaturated thioester in a single pot. This process is effected by reaction of the polyunsaturated alcohol with a sulphonyl halide, i.e. a compound of formula R2S02Hal where R2 is a Ci-20 hydrocarbyl group, preferably Ci-io hydrocarbyl group, especially Ci-io alkyl group, such as Ci-4 alkyl group, especially methyl. R2 is preferably a linear Ci-20 hydrocarbyl group such as linear Ci-io alkyl group.
The halide (hal) can be F, Cl, Br or I, especially Br or Cl, most especially Cl.
The reaction of the polyunsaturated alcohol with the sulphonyl halide is preferably effected in the presence of a base, ideally to neutralise any halide acids (e.g. HC1) that form during the reaction. The base should not itself react with the polyunsaturated compounds. Suitable bases are well known in the art, such as trialkylamines, in particular triethylamine. Well known non nucleophilic bases are therefore appropriate.
The starting material is preferably RICH2OH (XV), especially compounds (XII) or (XIV).
This reaction preferably forms therefore a compound of formula (XVI):
RICH2-0S02R2 (xvi) wherein Ri and R2 are as hereinbefore defined.
Step (f) of the process of the invention requires the conversion of the sulphonyl ester (XVI) into a polyunsaturated thioester. The -0S02R2 group is thus converted into -SC(=0)R4 group.
This can be achieved by reaction using a compound comprising a salt with a SCOR4 ion where R4 is a Ci-20 hydrocarbyl group. The counterion can be a metal such as an alkali metal, e.g. Li, Na or K. R4 is preferably a Ci-io hydrocarbyl group, especially a Ci-io alkyl group, such as Ci-6 alkyl group especially Ci-4 alkyl group such as methyl. Any R4 group is preferably linear. The use of a thioacetate ion is preferred.
The reaction forms a compound (XVII)
R1CH2-SCOR4 (XVII) wherein Ri and R4 are as hereinbefore defined.
This process should be effected in a single vessel. Steps e) and f) are carried out consecutively and preferably without a purification procedure between steps. It is preferred if step e) forms a precipitate. Once that precipitate is formed then a salt of-SC(=0)R4 such as a thioacetate salt can be added. There is no need to wash the precipitate or isolate the precipitate between its formation and the addition of the salt of-SC(=0)R4. In particular, aqueous or organic washing can be avoided between steps (e) and (f).
In a preferred embodiment, steps e) and f) involve the conversion of an alcohol of formula XIII or (XIV):
Figure imgf000026_0001
to a thioester of formula:
Figure imgf000026_0002
wherein R4 is as hereinbefore defined.
It is an preferred feature of the present invention that no purification occurs between steps e) and f).
The skilled person will be able to determine suitable to solvents to carry out step e) and f). THF is a preferred solvent or DMF. Steps e) and f) are preferably carried out in the same solvent.
A particularly preferred choice of thiocarboxylate is potassium thioacetate (KSC(=0)Me). Typically the crude product will be purified following completion of step f).
In some embodiments it may be appropriate to purify the crude thioester product after work-up of step f), typically by chromatographic purification. The purity of the thioester may be 70 to 100%, such as 80 to 100%, especially 90 to 100% as judged by chromatography.
Thioester to Thiol
The first and second embodiments discussed above produce intermediate compounds that are useful in the formation of certain target compounds such as compounds A and B identified above. The remaining steps required to convert the product of step (f) to the target compounds of the invention are known.
Target compounds of the invention are those of formula R1CH2-S- CH2COCF3 where Ri is as hereinbefore defined.
In a preferred embodiment, the invention provides a method of producing a pharmaceutically acceptable 1,1,1 -trifluoro-3-(((2E,6Z,9Z, 12Z, 15Z,)-octadeca- 2 , 6 , 9 , 12 , 15 -p entaein- 1 -y l)thio)prop an-2 -one :
Figure imgf000027_0001
where X is CF3; or related compound
Figure imgf000027_0002
where X is CF3.
One route from the alcohol is summarised below:
Figure imgf000028_0001
Scheme 2
To prepare these compounds, in step (g) of the process
Step g) - Deprotection
In step g) a thiocarboxylate is deprotected to provide a thiol. Deprotection may be by any means suitable, which include reaction with a base in an alcoholic solvent, such as potassium carbonate in methanol.
Preferably step g) is carried out in the presence of an antioxidant to prevent formation of the thiol. A preferred antioxidant is a-tocopherol.
The crude product from step g) is preferably used in step h) without purification.
Preferred thiols that are formed are simply of formula
R1CH2-SH wherein Ri is as hereinbefore defined.
The last step of the process of the invention therefore involves reaction of the thiol with a suitable ketone to form the desired compounds. The reaction preferably involves a compound is of formula (LG)CH2CO-X i.e.
Figure imgf000029_0001
RSR3COX
LG represents a leaving group which is nucleophilicly substituted by the thiol group. Preferably, the reagent is LG-CH2-COX, where LG is a leaving group such as a halide, tosyl, mesyl and so on. Ideally LG is a halide such as Br. X is preferably CF3. Most preferably (LG)R3-COX is BrCH2-COCF3.
This final reaction step may take place in the presence of anti-oxidant as hereinbefore defined. The use of tocopherol is especially preferred, particularly (+/- )-alpha-tocopherol.
In a preferred embodiment, the invention comprises a process comprising steps a-i) to a-iii) as herein defined and the subsequent conversion of the epoxide lower alkyl ester to the target compounds such R1CH2-S-CH2COCF3 where Ri is as hereinbefore defined;
Figure imgf000029_0002
e-g.
where X is CF3; or related compound
Figure imgf000029_0003
where X is CF3
In a second embodiment, the invention covers a process in which steps (e) and (f) as hereinbefore defined are carried out and the product thioester is converted to the target compounds such R1CH2-S-CH2COCF3 where Ri is as hereinbefore defined;
Figure imgf000029_0004
e-g- where X is CF3; or related compound
Figure imgf000030_0001
where X is CF3
In a most preferred embodiment, the invention provides a process comprising steps (a-i) to (a-iii) as hereinbefore defined, conversion of the epoxide to the corresponding alcohol (steps b-d), followed by steps (e) and (f) as hereinbefore defined and conversion of the thioester to the target compounds such RiCFb-S- CH2COCF3 where Ri is as hereinbefore defined;
Figure imgf000030_0002
e-g.
where X is CF3; or related compound
Figure imgf000030_0003
where X is CF3
It will be appreciated that the compounds made in the process of the invention have a variety of applications, e.g. in the treatment of chronic
inflammatory disorders. They can be formulated as pharmaceutical compositions using well known techniques. They may be converted into salts where appropriate. A further discussion of such techniques is not required here. In one embodiment therefore the invention provides:
Figure imgf000031_0001
Steps a-i to a-iii and (e)-(f) are carried out in one pot as herein defined. The invention will now be described with reference to the following non limiting examples and figures.
Description of the Figures
Figure 1. HPLC of starting material DHA ethyl ester.
Figure 2. HPLC of crude material after step a-i) on 200 g scale.
Figure 3. HPLC of crude iodolactone after step a-ii) on 200 g scale.
Figure 4a. HPLC of crude epoxide after step a-iii) on 200 g scale.
Figure 4b. 1H NMR of crude epoxide after step a-iii) on 200 g scale.
Figure 4c. 1H NMR of crude epoxide where work-up procedures were performed at the end of steps a-i) and a-ii).
Figure 5. 1H NMR of crude thioacetate made from the one-pot synthesis.
Example 1: One-pot Synthesis of Methyl 3-(3-((2Z,5Z,8Z,l lZ,14Z)-heptadeca- 2,5,8,ll,14-pentaen-l-yl)oxiran-2-yl)propanoate
Figure imgf000032_0002
A mixture of DHA ethyl ester (5.00 g, 14.0 mmol) and LiOH H20 (95.3 mmol) in MeOH/water (50 ml / 20 ml) was stirred at 60 °C under N2-atmosphere for 50 minutes. The reaction mixture was cooled to room temperature and added 3 M HC1 in MeOH to pH ~5. Potassium iodide (2.805 g, 16.9 mmol) and KHCO3 (8.42 g, 84.1 mmol) was added and the reaction mixture was stirred for 10 minutes at room temperature before addition of iodine (4.277, 16.9 mmol) was added. The reaction mixture was stirred for 19 hrs. NaHCCh (1.958 g, 23.3 mmol) and Na2S03 (1.552 g, 12.3 mmol) was added and the reaction mixture was stirred for 40 minutes. Potassium carbonate (5.879 g, 42.5 mmol) was added and the reaction mixture was stirred for 24 hrs. HPLC and TLC of the reaction mixture confirmed formation of the title compound.
This crude 1 H NMR (Figure 4a) corresponds well with the 1 H NMR obtained from the reactions where DHA is worked-up.
Example 2: Preparation of (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenal
Figure imgf000032_0001
A solution of methyl 3-(3-((2Z,5Z,8Z,l lZ,l4Z)4ieptadeca-2, 5,8,1 l,l4-pentaen-l- yl)oxiran-2-yl)propanoate (100.7 mg, 0.279 mmol) in dry diethyl ether (3 ml) was flushed with N2, capped and added a solution of H5IO6 (130.5 mg, 0.57 mmol) in dry THF (2 ml) drop wise over 5 minutes. The reaction mixture was stirred at room temperature for 1 hr, diluted with heptane (25 ml) and washed with NaHCCh (sat) (aq) (15 ml) the water phase was extracted with heptane (25 ml) and the combined organic phase was dried (Na2S04), filtered and concentrated under reduced pressure to afford the crude title compound as a dark yellow oil. Isomerisation of (3Z,6Z,9Z,l2Z,l5Z)-octadeca-3,6,9,l2,l5-pentaenal to the trans-Cl8 alcohol is then carried out following procedures described in W02015/011206.
Figure imgf000033_0001
trans C-18 aldehyde ^ ^ trans C-18 alcohol
Chemical Formula: C-igl^O Chemical Formula: C-igFksO Molecular Weight: 258,40 Molecular Weight: 260,41 0 A solution of trans C-18 aldehyde (96.31 g, 372.7 mmol) in dry toluene (1 L) was cooled to - 78 °C under N2-atmosphere. DIBAL-H 1 M in toluene (in hexanes also works) (456.8 mL, 456.8 mmol) was added drop wise through a dropping funnel over 20 minutes. The reaction mixture was stirred at - 78 °C for 1 hr. 6 M HC1 (aq) (100 mL) was added drop wise / portion wise through the dropping funnel. The 5 cooling bath was removed and the reaction mixture was stirred for 30 minutes. Brine (1 L) was added and the reaction mixture was extracted with diethyl ether (4 x 500 mL). The combined organic phase was dried (Na2S04), filtered and concentrated under reduced pressure to afford crude trans C-18 alcohol. (Store crude alcohol at - l8°C under argon.) Careful purification by chromatography is subsequently carried0 out.
Example 3 - One pot conversion of polyunsaturated alcohol to thioester
S-((2L,6Z,9Z, 12 Z, 15Z)-octadeca-2,6,9, 12, 15-pentaen- 1 -yl) ethanethioate
Figure imgf000033_0002
A solution of (2L,6Z,9Z,l2Z,l5Z)- octadeca-2,6,9,l2,l5-pentaen-l-ol (30.11 g, 115.6 mmol) in dry THF (300 ml) was flushed with N2 before addition of mesyl chloride (11.6 ml, 149.9 mmol) and triethyl amine (32 ml, 229.9 mmol) and capped. The reaction was exothermic and a precipitate was formed. The reaction mixture was stirred for 1 hr before potassium thioacetate (26.3 g, 230.3 mmol) and DMF (60 ml) was added. The reaction mixture was stirred for 18.5 hrs and diluted with water (500 ml) and extracted with heptane (300 ml x 3). The combined organic phase was washed with brine (150 ml), dried (Na2S04), filtered and concentrated under reduced pressure. Dry-flash chromatography on silica gel (1 kg) eluting with heptane - heptane:EtOAc (100:1) afforded 29.12 g (79 %) of the title compound as a yellow oil. 1H NMR (400 MHz, CDCb) d 5.75 - 5.56 (m, 1H), 5.51 - 5.18 (m, 9H), 3.48 (d, J= 7.1, 2H), 2.97 - 2.71 (m, 6H), 2.30 (s, 3H), 2.20 - 1.87 (m, 6H), 0.96 (t, J= 7.5, 3H). Example 4: Synthesis of Compound A
Figure imgf000034_0001
3 4 The compound of example 3 (5.27 g, 16.5 mmol) was dissolved in methanol (50 mL) containing 10 mg alpha-tocopherol. Potassium carbonate (2.53 g, 18. mmol) was added in one portion at room temperature and the mixture was stirred for 45 minutes under inert atmosphere. The reaction mixture was quenched by way of drop-wise addition of 50 mL 1 M HC1, while cooled on an ice-bath. Subsequently, the mixture was extracted with heptane (3 x 50 mL), and the combined organic phases washed with brine (50 mL). Drying over Na2S04 and subsequent filtration and removal of solvent under reduced pressure provided 4.45 g of 4 (97.5% yield) as an orange oil. The crude product was used in the next step without further purification.
Figure imgf000035_0001
4 Compound A
Sodium hydrogen carbonate (2.87 g, 34.2 mmol) was added to thiol 4 (4.45 g, 16.1 mmol), followed by water (50 mL) and ethanol (75 mL). The resulting inhomogeneous mixture was stirred vigorously at room temperature for 20 min under inert atmosphere. 3-Bromo-l,l,l-trifluoroacetone (2.1 ml, 20 mmol) was then added in one portion, and stirring was continued for 45 minutes. The reaction mixture was extracted with «-heptane (2 x 100 ml). The combined organic phase was washed with brine (50 mL), dried over Na2S04, filtered and concentrated under reduced pressure. This afforded 6.26 g crude product.
From the crude product, two 2.00 g aliquots were withdrawn and purified further using two different methods.
(Y) One aliquot was applied to a 90 g silica column and eluted by way of dry column vacuum chromatography (DCVC, 100 mL fractions, gradient elution
«-heptane - 100:2 «-heptane: ethyl acetate). Pure fractions were combined and evaporation of solvent under reduced pressure gave 1.64 g of 5 as a pale yellow oil. This corresponds to 82.5% yield for the last step. (Z) second aliquot was applied to a column with 90 g ODS-AQ stationary phase. Elution was performed by way of DCVC (100 mL fractions, gradient elution 20:80 acetonitrile: water - 70:30 acetonitrile: water), and after evaporation of acetonitrile from the fractions containing pure product, the product was extracted back to an organic solvent with 3 x 100 mL «-heptane. The combined organic extracts were washed with brine (50 mL), dried over
Na2S04, filtered and concentrated under reduced pressure to give 1.28 g of 5 as a pale orange oil. This corresponds to 64.4% yield for the last step. Mass and NMR spectral data are similar, except for ratio hydrated/unhydrated in NMR. The given data are for purification method Z).
1 H NMR (mixture of hydrated/unhydrated), CDCb, 400 MHz):□ 0.98 (3H, t, J = 5 7.5 Hz), 2.08 (2H, dq, Ji = Ji = 7.4 Hz), 2.12-2-21 (4H, m), 2.76-2.89 (6H, m), 3.10
(0.5H, t, J= 7.5 Hz), 3.26 (1.5H, t, J= 7.5 Hz ), 3.45 (0.5H, s), 3.93 (1.5H, s), 5.28- 5.46 (9H, m), 5.56-5.66 (1H, m). MS (ES): m/z 385 (M-H+) .
The products from purification method Y) and Z) were analysed by HPLC and the 0 impurities were compared with impurities in a batch prepared with a sequential thioester production step with work up between steps. The results are shown in Table 1 below
Table 1 Results for impurities in Compound A
Figure imgf000036_0001
Figure imgf000037_0001
**; RRT(Relative Retention Time), these are approximate values and will vary slightly between runs.
***; Exact RRT is 1.39. The identity has been confirmed by HPLC analysis of reference of impurity 7.
ND; Not detected
N/A Method run; 22 minutes
LOQ; Limit of quantification = 0.05%
****It should be noted that the peaks at RRT > 3 might be HPLC an artifact
COMPARATIVE EXAMPLE 1
A polyunsaturated alcohol was made according to a method described in PCT/EP2014/065853. The synthetic scheme used (Scheme 1) is shown below:
Figure imgf000038_0001
Comparative Scheme 1
To obtain the key trans C-18 alcohol in the required purity time -intensive chromatography is required.

Claims

Claims
1. A process comprising the steps of:
(a) combining, in a vessel, a polyunsaturated ester and a halolactonization 5 agent in a solvent of lower alcohol and water to form a mixture,
(ab) treating, e.g. heating the mixture in the presence of a reagent and under conditions sufficient to form a polyunsaturated epoxide lower alkyl ester in the vessel.
10 2. A process comprising the following steps:
a-i) treating a polyunsaturated ester with a base in a solvent of lower alcohol and water to form the corresponding polyunsaturated acid;
a-ii) treating the product from step a-i), especially the crude product, with a halolactonization agent in the solvent of lower alcohol and water, to form the 15 corresponding polyunsaturated halolactone; and
a-iii) treating the product from step a-ii), especially the crude product, with a reagent in the solvent of lower alcohol and water to convert the polyunsaturated halolactone to the corresponding polyunsaturated epoxide lower alkyl ester.
20 3. A process as claimed in claim 2 wherein steps a-i) to a-iii) are carried out in the same reaction vessel.
4. A process as claimed in claim 2 to 3 wherein the process proceeds without purification by chromatography and/or distillation between steps a-i)/a-ii) and/or between ¾Seps a-ii)/a-iii).
5. A process comprising the following steps:
(a-i) treating a polyunsaturated alkyl ester of formula (G)
30 RI-CH=CH-CH2CH2COOR6 (G) such as the compound
Figure imgf000040_0001
wherein R1 is an optionally substituted CY22 unsaturated hydrocarbon group, said hydrocarbon group comprising at least 2, preferably at least 4 double bonds; and R6 is a C1-C4 alkyl group;
with a base in a solvent of lower alcohol/water to form the corresponding polyunsaturated acid of formula (IF):
RI-CH=CH-CH2CH2COOH (IF) such as the compound
Figure imgf000040_0002
wherein Ri is as hereinbefore defined;
a-ii) treating the product from step a-i) with a iodolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone compound:
Figure imgf000040_0003
wherein Ri is as hereinbefore defined; and
a-iii) treating the product from step a-ii) with a reagent in the solvent of lower alcohol/water to convert the iodolactone to the corresponding polyunsaturated epoxide lower alkyl ester of formula (IV):
Figure imgf000041_0001
wherein Ri is as hereinbefore defined and Rs is Ci-4alkyL
6. A process comprising the following steps:
a-i) treating a polyunsaturated alkyl ester of formula (VI):
Figure imgf000041_0002
wherein R6 is a C1-C4 alkyl group;
with a base in a solvent of lower alcohol and water to form the corresponding polyunsaturated acid;
a-ii) treating the product from step a-i) with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding halolactone; and a-iii) treating the product from step a-ii) with a reagent in the solvent of lower alcohol and water to convert the halolactone to the corresponding epoxide of formula (IX):
Figure imgf000041_0003
wherein Rs is Ci-4alkyl.
7. A process as claimed in claim 2 to 6 wherein lower alcohol is methanol or ethanol.
8. A process as claimed in claim 2 to 7 wherein the base in step a-i) is LiOH.
9. A process as claimed in claim 2 to 8 wherein the volume of lower alcohol: water in step a-i) is 50:50 to 90:10 (vol/vol), e.g. 55:45 to 85:15 (vol/vol).
10. A process as claimed in claim 2 to 9 wherein the molar ratio of
halolactonization agent added in step a-ii) : ester added in step a-i) is 1.05:1 to 1.5:1.
11. A process as claimed in any preceding claim wherein said halolactonization agent is I2.
12. A process as claimed in claim 2 to 11 wherein lower alcohol is methanol and the volume of MeOH : water in step a-iii) is 70:30 to 95:5 (vol/vol).
13. A process as claimed in claim 2 to 12 wherein step a-iii) involves the addition of a metal carbonate such as K2CO3.
14. A process as claimed in any preceding claim wherein the purity of the epoxide is 70 to 100% when measured by HPLC on the crude product, e.g. of step a- iii) in accordance with the HPLC method in the Experimental Section, preferably 80-100%.
15. A process as claimed in claim 2 to 14 wherein steps (a-i) to (a-iii) are carried out at a temperature of 25 to l00°C, such as 50 to 80°C.
16. A process as claimed in claim 2 to 15 wherein step a-iii) is followed by a step b) of converting the epoxide to an aldehyde, e.g. one of formula (X):
Figure imgf000042_0001
preferably wherein no purification is carried out between steps a-iii) and b).
17. A process as claimed in claim 16 wherein step b) is carried out using H5IO6.
18. A process as claimed in any of claims 16 or 17 wherein step b) is followed by a step c) of isomerizing the aldehyde of formula (X) to an aldehyde of formula
(XI):
Figure imgf000043_0001
using an amine base.
19. A process as claimed in claim 18 wherein step c) is carried out using DBU in diethyl ether.
20. A process as claimed in any of claims 16 to 19 wherein step b) or c) is followed by a step d) of converting the aldehyde into an alcohol.
21. A process for the preparation of a polyunsaturated thioester comprising:
(e) reacting a polyunsaturated alcohol in the presence of a compound of formula R2-S02Hal wherein R2 is a Ci-20 hydrocarbyl group, such an Ci-io alkyl group, to form a polyunsaturated sulphonyl ester;
(f) converting the polyunsaturated sulphonyl ester to a polyunsaturated thioester by reacting with an anion of formula SC(=0)R4 wherein R4 is a Ci-20 hydrocarbyl group;
wherein steps (e) and (f) are carried out sequentially or preferably consecutively in one vessel.
22. A process including at least the following steps:
(e) reacting a polyunsaturated alcohol of formula (XV)
R1CH2OH (XV) wherein R1 is an optionally substituted CY22 unsaturated hydrocarbon group, said hydrocarbon group comprising at least 2, preferably at least 4 double bonds; in the presence of a compound of formula R2-S02Hal wherein R2 is a Ci-20 hydrocarbyl group, such an Ci-io alkyl group, to form a polyunsaturated sulphonyl ester of formula (XVI)
RICH20S02R2 (XVI); (f) converting the polyunsaturated sulphonyl ester of formula (XVI) to a polyunsaturated thioester (XVII)
RICH2SC(=0)R4 (XVII) by reacting with an anion of formula SC(=0)R4 wherein R4 is a Ci-20 hydrocarbyl group;
wherein steps (e) and (f) are carried out consecutively in one pot.
23. A process including at least the following steps:
(e) reacting (3Z,6Z,9Z,l2Z,l5Z)-octadeca-3,6,9,l2,l5-pentaen-l-ol
Figure imgf000044_0001
with methanesulphonyl chloride in the presence of a base so as to form a
Figure imgf000045_0001
(f) reacting the reaction product of step (e) with a thioacetate ion to form a thioester of formula:
Figure imgf000045_0002
wherein steps (e) and (f) are carried out consecutively in one pot.
24. A process as claimed in claims 21 to 23 wherein there are no purification steps between steps (e) and (f).
25. A process as claimed in claim 21-24 wherein said sulfonyl ester is ClSC Me, tosyl chloride, brosyl chloride, nosyl chloride, triflyl chloride, tresyl chloride and dansyl chloride.
26. A process as claimed in claim 21-25 wherein step e) is carried out in the presence of an amine base.
27. A process as claimed in claim 21-26 wherein step e) is carried out in the presence of triethylamine.
28. A process as claimed in any of claims 21-28 wherein step e) is preceded by steps a) to d) as defined in claims 1 to 20.
29. A process as claimed in claim 21-28 wherein step f) is carried out by reacting with potassium thioacetate in DMF.
30. A process as claimed in any preceding claim wherein the purity of the thioester is 70 to 100% when measured by HPLC on the crude product of step f) in accordance with the HPLC method in the Experimental Section, preferably 80- 100%.
31. A process as claimed in any of claims 21-30 wherein step f) is followed by converting the thioester to compound A or B:
Figure imgf000046_0001
Compound B
Figure imgf000046_0002
Compound A wherein X is CF3.
32. A process as claimed in any of claims 1-4 wherein step a-iii) is followed by converting the epoxide to compound A or B:
Figure imgf000046_0003
Compound B
Figure imgf000047_0001
Compound A wherein X is CF3.
33. A process comprising the following steps:
a-i) treating a polyunsaturated ester with a base in a solvent of lower alcohol and water to form the corresponding polyunsaturated acid;
a-ii) treating the product from step a-i) with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding polyunsaturated halolactone;
a-iii) treating the product from step a-ii) with a reagent in the solvent of lower alcohol and water to convert the polyunsaturated halolactone to the corresponding polyunsaturated epoxide lower alkyl ester;
b-d) converting said polyunsaturated epoxide lower alkyl ester into the corresponding polyunsaturated alcohol;
(e) reacting said polyunsaturated alcohol in the presence of a compound of formula R2-S02Hal wherein R2 is a Ci-20 hydrocarbyl group, such an Ci-io alkyl group, to form a polyunsaturated sulphonyl ester;
(f) converting the polyunsaturated sulphonyl ester to a polyunsaturated thioester by reacting with an anion of formula SC(=0)R4 wherein R4 is a Ci-20 hydrocarbyl group;
wherein steps (e) and (f) are carried out consecutively in one pot;
(g) converting the polyunsaturated thioester to a polyunsaturated ketone, e.g. compound A or B.
34. A process comprising the following steps:
a-i) treating a polyunsaturated alkyl ester of formula (VI):
Figure imgf000048_0001
wherein R6 is a C1-C4 alkyl group;
with a base in a solvent of lower alcohol and water to form the corresponding polyunsaturated acid;
a-ii) treating the product from step a-i) with a halolactonization agent in the solvent of lower alcohol and water, to form the corresponding halolactone; and a-iii) treating the product from step a-ii) with a reagent in the solvent of lower alcohol and water to convert the halolactone to the corresponding epoxide of formula (IX):
Figure imgf000048_0002
wherein Rs is Ci-4alkyl; b) converting the epoxide to an aldehyde of formula (X):
Figure imgf000048_0003
optionally;
c) isomerizing the aldehyde of formula (X) to an aldehyde of formula (XI):
Figure imgf000048_0004
d) converting the aldehyde (X) or (XI) into an alcohol; (3Z,6Z,9Z,12Z,15Z)- octadeca-3,6,9,l2,l5-pentaen-l-ol
Figure imgf000049_0003
(e) reacting said alcohol with methanesulphonyl chloride in the presence of a base so as to form
Figure imgf000049_0001
(f) reacting the reaction product of step (e) with a thioacetate ion to form a thioester of formula:
Figure imgf000049_0002
Figure imgf000050_0001
wherein steps (e) and (f) are carried out consecutively in one pot; and g) converting the thioester to compound A or B;
Figure imgf000050_0002
Compound B
Figure imgf000050_0003
Compound A wherein X is CF3.
PCT/EP2019/062506 2018-05-15 2019-05-15 Processes in the preparation of polyunsaturated ketone compounds WO2019219758A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1807892.3 2018-05-15
GBGB1807892.3A GB201807892D0 (en) 2018-05-15 2018-05-15 Processes in the preparation of polyunsaturated ketone compounds

Publications (1)

Publication Number Publication Date
WO2019219758A1 true WO2019219758A1 (en) 2019-11-21

Family

ID=62623131

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2019/062506 WO2019219758A1 (en) 2018-05-15 2019-05-15 Processes in the preparation of polyunsaturated ketone compounds

Country Status (2)

Country Link
GB (1) GB201807892D0 (en)
WO (1) WO2019219758A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687543B2 (en) 2002-01-29 2010-03-30 Avexxin As Use of polyunsaturated ketones for the treatment of psoriasis
WO2015011206A1 (en) 2013-07-24 2015-01-29 Avexxin As Process for the preparation of a polyunsaturated ketone compound
WO2016116634A1 (en) 2015-01-23 2016-07-28 Avexxin As Process for the preparation of a polyunsaturated ketone compound
WO2016116334A1 (en) 2015-01-22 2016-07-28 Spx Flow Technology Norderstedt Gmbh Process pump having a crank drive

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687543B2 (en) 2002-01-29 2010-03-30 Avexxin As Use of polyunsaturated ketones for the treatment of psoriasis
WO2015011206A1 (en) 2013-07-24 2015-01-29 Avexxin As Process for the preparation of a polyunsaturated ketone compound
WO2016116334A1 (en) 2015-01-22 2016-07-28 Spx Flow Technology Norderstedt Gmbh Process pump having a crank drive
WO2016116634A1 (en) 2015-01-23 2016-07-28 Avexxin As Process for the preparation of a polyunsaturated ketone compound

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANNE KRISTIN HOLMEIDE ET AL: "Syntheses of some polyunsaturated trifluoromethyl ketones as potential phospholipase A2 inhibitors", ROYAL CHEMICAL SOCIETY. JOURNAL. PERKIN TRANSACTIONS 1, vol. 1, no. 14, 2000, GB, pages 2271 - 2276, XP055539908, ISSN: 1470-4358, DOI: 10.1039/b001944p *
ANNE LANGSETER ET AL: "Synthesis of All-Z-1,6,9,12,15-Octadecapenten-3-one, A Vinyl Ketone Polyunsaturated Marine Natural Product Isolated from Callysponga sp.", MOLECULES, vol. 19, no. 3, 24 March 2014 (2014-03-24), pages 3804 - 3812, XP055602257, DOI: 10.3390/molecules19033804 *
FLOCK ET AL., ACTA CHEMICA SCANDINAVIA, vol. 54, 1999, pages 436 - 445
FLOCK S ET AL: "SYNTHESES OF SOME POLYUNSATURATED SULFUR- AND OXYGEN-CONTAINING FATTY ACIDS RELATED TO EICOSAPENTAENOIC AND DOCOSAHEXAENOIC ACIDS", ACTA CHEMICA SCANDINAVICA, MUNKSGAARD, COPENHAGEN, DK, vol. 53, no. 6, 1999, pages 436 - 445, XP001148989, ISSN: 0904-213X *
HOLMEIDE, AL. SKATTEBOL, J. CHEM. SOC. PERKIN TRANS., vol. 1, 2000, pages 2271
HUWILER, A ET AL., BR. J. PHARM., vol. 167, 2012, pages 1691

Also Published As

Publication number Publication date
GB201807892D0 (en) 2018-06-27

Similar Documents

Publication Publication Date Title
Davis et al. Asymmetric synthesis of sulfinimines: applications to the synthesis of nonracemic. beta.-amino acids and. alpha.-hydroxyl. beta.-amino acids
JP7330537B2 (en) Preparation of 3-hydroxy-3,6-dimethylhexahydrobenzofuran-2-one and its derivatives
US6927300B2 (en) Process for the preparation of Latanoprost
EP0515541B1 (en) METHOD FOR PREPARING CIS-$g(b)-PHENYLGLYCIDIC-(2R,3R) ACID
AU2018205146A1 (en) Process for the preparation of a polyunsaturated ketone compound
WO2019219758A1 (en) Processes in the preparation of polyunsaturated ketone compounds
JPS59137445A (en) Prostacylcin and preparation thereof
US9725392B2 (en) Efficient scalable syntheses of abscisic acid, 8′-acetylene abscisic acid and 8′-cyclopropyl abscisic acid
Ramana Reddy et al. Thioglycolates in the Synthesis of Bis (styryl)-sulfones
JPH10504321A (en) Preparation of prostaglandins E1, E2 and their analogs using furyl copper reagent
AU2017401930B2 (en) Efficient scalable syntheses of abscisic acid, 8'-acetylene abscisic acid and 8'-cyclopropyl abscisic acid
KR20020079555A (en) Practical Synthetic Method of Retinoid and Carotenoid Compounds
FR2636624A1 (en) METHOD FOR STEREOCHIMIC INVERSION OF HYDROXY FUNCTION OF AN ESTER BY MODIFIED MITSUNOBU REACTIONAL PROCESS
KR950008080B1 (en) Hplc chiral column for optical resolution of racemic amino acids
FR2534917A1 (en) EPOXYCARBACYCLINES, PROCESS FOR PREPARING THEM AND THEIR APPLICATION
JP2023512405A (en) Process for the preparation of chiral prostaglandin enol intermediates and intermediate compounds useful in this process
JPS6287599A (en) Production of oxime derivative of erythromycin
EP0466583B1 (en) Process for the preparation of 2,5-dimethyl-4-hydroxy-3(2H)-furanone
FR2590894A1 (en) AMINO-4-BUTANOIC ACID DERIVATIVES, PROCESS FOR PREPARING SAME AND USE THEREOF
FR2494696A1 (en) NOVEL PROCESS FOR THE PREPARATION OF 3-AMINO STEROIDS AND THEIR SALTS
BE818471A (en) PROCESS FOR PREPARING 1-ARALKYL-4-AMINO-METHYLPIPERIDINE-4-OLS
JPH0415222B2 (en)
WO2006001562A1 (en) A process for optical pure (r)-2-phenoxypropionic acid derivatives
FR2588862A1 (en) PROCESS FOR THE PREPARATION OF 2E, 4E-CARBOXYLIC ACIDS
JPS59231066A (en) Preparation of 6-oxoprostaglandin e1 compound

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19727300

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 19727300

Country of ref document: EP

Kind code of ref document: A1